<SEC-DOCUMENT>0001437749-23-018015.txt : 20230621
<SEC-HEADER>0001437749-23-018015.hdr.sgml : 20230621
<ACCEPTANCE-DATETIME>20230621172334
ACCESSION NUMBER:		0001437749-23-018015
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20230621
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230621
DATE AS OF CHANGE:		20230621

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioCardia, Inc.
		CENTRAL INDEX KEY:			0000925741
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				232753988
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38999
		FILM NUMBER:		231030896

	BUSINESS ADDRESS:	
		STREET 1:		320 SOQUEL WAY
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94085
		BUSINESS PHONE:		650-226-0123

	MAIL ADDRESS:	
		STREET 1:		320 SOQUEL WAY
		CITY:			SUNNYVALE
		STATE:			CA
		ZIP:			94085

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tiger X Medical, Inc.
		DATE OF NAME CHANGE:	20110616

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cardo Medical, Inc.
		DATE OF NAME CHANGE:	20081027

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLICKNSETTLE COM INC
		DATE OF NAME CHANGE:	20000823
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bcda20230621_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:bcda="http://www.bcda.com/20230621"><head>
	<title>bcda20230621_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 6/21/2023 9:12:40 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20238K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20238K" name="dei:EntityCentralIndexKey">0000925741</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="bcda-20230621.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20238K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-06-21</xbrli:startDate>
<xbrli:endDate>2023-06-21</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="d20238K_StatementClassOfStockAxis_CommonStockParValue0001">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bcda:CommonStockParValue0001CustomMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-06-21</xbrli:startDate>
<xbrli:endDate>2023-06-21</xbrli:endDate>
</xbrli:period>
</xbrli:context>

<xbrli:context id="d20238K_StatementClassOfStockAxis_WarrantToPurchaseCommonStock">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000925741</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bcda:WarrantToPurchaseCommonStockCustomMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2023-06-21</xbrli:startDate>
<xbrli:endDate>2023-06-21</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION </b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20238K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="d20238K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b>June 21, 2023</b></ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityRegistrantName"><b>BIOCARDIA, INC.</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityFileNumber"><b>0-21419</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityTaxIdentificationNumber"><b>23-2753988</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State or other jurisdiction</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">of incorporation)</div>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">File Number)</div>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(IRS Employer</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Identification No.)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressAddressLine1"><b>320 Soquel Way</b></ix:nonNumeric>&#xa0;<br />
			<b><ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressCityOrTown"><b>Sunnyvale</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20238K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince"><b>California</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20238K" name="dei:EntityAddressPostalZipCode"><b>94085</b></ix:nonNumeric></b></div>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices and zip code)</div>
			</td>
			<td style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Registrant</b>&#8217;<b>s telephone number, including area code: (<ix:nonNumeric contextRef="d20238K" name="dei:CityAreaCode"><b>650</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20238K" name="dei:LocalPhoneNumber"><b>226-0120</b></ix:nonNumeric></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto" />
<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: middle; width: auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Title of each class</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: auto; border-top: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Trading Symbol(s)</div>
			</td>
			<td style="border-color: black black rgb(0, 0, 0); border-style: solid; border-width: 1px; vertical-align: middle; width: auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Name of each exchange on which registered</div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001" name="dei:Security12bTitle">Common Stock, par value $0.001</ix:nonNumeric></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001" name="dei:TradingSymbol">BCDA</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</div>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantToPurchaseCommonStock" name="dei:Security12bTitle">Warrant to Purchase Common Stock</ix:nonNumeric></div>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantToPurchaseCommonStock" name="dei:TradingSymbol">BCDAW</ix:nonNumeric></div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">The <ix:nonNumeric contextRef="d20238K_StatementClassOfStockAxis_WarrantToPurchaseCommonStock" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> Capital Market</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter) <ix:nonNumeric contextRef="d20238K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 8.01 Other Events</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On June 21, 2023, BioCardia, Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with certain existing investors and other institutional investors, as well as certain directors and officers of the Company (the &#8220;Purchasers&#8221;), pursuant to which the Company agreed to sell and issue to the Purchasers an aggregate of 1,133,141 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), in a registered direct offering (the &#8220;Offering&#8221;) at an offering price of $2.336 per share. Certain of the Company&#8217;s directors and executive officers agreed to purchase an aggregate of 203,337 shares of Common Stock in the Offering. The Offering is expected to close on or about June 23, 2023, subject to satisfaction of customary closing conditions.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The gross proceeds of the Offering will be approximately $2.6 million, before deducting placement agent fees and expenses, and offering expenses payable by the Company. The Company intends to use the net proceeds from the Offering for working capital and other general corporate purposes.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Shares are being offered pursuant to the Company&#8217;s effective registration statement on Form S-3 and accompanying base prospectus (File No. 333-249426), previously filed with and declared effective by the Securities and Exchange Commission.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Titan Partners Group LLC, a division of American Capital Partners, LLC (the &#8220;Placement Agent&#8221;) acted as the exclusive placement agent for the Offering. We have agreed to pay the Placement Agent a placement agent fee in an amount equal to seven percent 7% of the aggregate gross proceeds in the Offering other than to certain insiders and other identified investors, for which there will be no cash fee with respect to the gross proceeds received by the Company from such persons, and to reimburse up to $45,000 of the Placement Agent&#8217;s out-of-pocket legal expenses.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Purchase Agreement contains customary representations, warranties and agreements by the Company, conditions to closing, indemnification obligations of the Company and the Purchasers, other obligations of the parties and termination provisions. The representations, warranties and covenants contained in the Purchase Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties.</div>

<div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The foregoing description of the Purchase Agreement is not complete and is qualified in its entirety by reference to the full text of the form of Purchase Agreement, a copy of which is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Item 9.01 Financial Statements and Exhibits.</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 95%; margin-left: 18pt; margin-right: auto;">

		<tbody><tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="vertical-align: bottom; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Exhibit</b></div>

			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Number</b></div>
			</td>
			<td colspan="3" style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="3" style="vertical-align: bottom; width: 91%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid black;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Description</b></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="vertical-align: middle; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="3" style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="3" style="vertical-align: middle; width: 91%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="vertical-align: top; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">5.1</div>
			</td>
			<td colspan="3" style="vertical-align: top; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>
			</td>
			<td colspan="3" style="vertical-align: top; width: 91%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="ex_536556.htm" style="-sec-extract:exhibit;">Opinion of Wilson Sonsini Goodrich &amp; Rosati.</a></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="vertical-align: top; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">23.1</div>
			</td>
			<td colspan="3" style="vertical-align: top; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>
			</td>
			<td colspan="3" style="vertical-align: top; width: 91%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="ex_536556.htm" style="-sec-extract:exhibit;">Consent of Wilson Sonsini Goodrich &amp; Rosati (included in the opinion of Wilson Sonsini Goodrich &amp; Rosati filed as Exhibit 5.1 hereto).</a></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="vertical-align: top; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">99.1</div>
			</td>
			<td colspan="3" style="vertical-align: top; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>
			</td>
			<td colspan="3" style="vertical-align: top; width: 91%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><a href="ex_536281.htm" style="-sec-extract:exhibit;">Form of Securities Purchase Agreement, dated June 21, 2023, by and among the Company and each Purchaser party thereto.</a></div>
			</td>
		</tr>
		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td colspan="3" style="vertical-align: top; width: 7%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">104</div>
			</td>
			<td colspan="3" style="vertical-align: middle; width: 2%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#xa0;</td>
			<td colspan="3" style="vertical-align: top; width: 91%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<div style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
-2-
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td colspan="3" style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>BIOCARDIA, INC.</b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:bottom;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Date: June 21, 2023</div>
			</td>
			<td colspan="3" style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By:</div>
			</td>
			<td colspan="3" style="vertical-align: bottom; width: auto; border-bottom: 1px solid black;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">/s/ Peter Altman, Ph.D.</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td colspan="3" style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Name: Peter Altman, Ph.D.</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td colspan="3" style="vertical-align:middle;width:auto;">&#xa0;</td>
			<td colspan="3" style="vertical-align:top;width:auto;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title: President and Chief Executive Officer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
-3-
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ex_536556.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html><head>
	<title>ex_536556.htm</title>

	<!-- Generated by ThunderDome Portal - 6/21/2023 9:09:57 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 5.1</b></font></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 75%; vertical-align: top;">
			<div><img alt="ws01.jpg" src="ws01.jpg"></div>
			</td>
			<td style="width: 25%;">
			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">&nbsp;</p>

			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">Wilson Sonsini Goodrich &amp; Rosati<br>
			Professional Corporation</p>

			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">&nbsp;</p>

			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">650 Page Mill Road<br>
			Palo Alto, CA 94304-1050</p>

			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">&nbsp;</p>

			<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif;">o: 650.493.9300<br>
			f: 650.493.6811</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">June 21, 2023</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">BioCardia, Inc.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">320 Soquel Way</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sunnyvale, California 94085</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Re:</b></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b><u>Registered Direct Offering</u></b></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ladies and Gentlemen:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We have acted as counsel to BioCardia Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), in connection with the registration of the offer and sale of an aggregate of 1,133,141 shares (the &#8220;<u>Shares</u>&#8221;) of the Company&#8217;s common stock, $0.001 par value per share (&#8220;<u>Common Stock</u>&#8221;), pursuant to the Company&#8217;s Registration Statement on Form S-3 (File No. 333-249426) initially filed on October 9, 2020 and declared effective by the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) on October 20, 2020 (the &#8220;<u>Registration Statement</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The offering and sale of the Securities are being made pursuant to that certain Securities Purchase Agreement, dated as of June 21, 2023, by and among the Company and the purchaser identified in the signature pages thereto (the &#8220;<u>Securities Purchase Agreement</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">As such counsel, we have made such legal and factual examinations and inquiries as we have deemed necessary or advisable for the purpose of rendering the opinions and statements set forth below. In rendering the opinions and statements expressed below, we have examined originals or copies, certified or otherwise identified to our satisfaction, of such documents, corporate records, certificates of public officials and other instruments as we have deemed necessary for the purposes of rendering this opinion.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">In addition, we have reviewed originals or copies of such corporate records of the Company, certificates of public officials and such other documents which we consider necessary or advisable for the purpose of rendering the opinions set forth below. We have not independently established the facts stated therein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">In our examination, we have assumed the genuineness of all signatures, the authenticity and completeness of all documents submitted to us as originals, the conformity with the originals of all documents submitted to us as copies, the authenticity of the originals of such documents and the legal competence of all signatories to such documents. We have also assumed the authority of such persons signing on behalf of the parties thereto other than the Company and the due authorization, execution and delivery of all documents by the parties thereto other than the Company. We have also assumed<i> </i>the conformity of the documents filed with the Commission via the Electronic Data Gathering, Analysis and Retrieval System (&#8220;<u>EDGAR</u>&#8221;), except for required EDGAR formatting changes, to physical copies submitted for our examination and the absence of any evidence extrinsic to the provisions of the written agreements between the parties that the parties intended a meaning contrary to that expressed by those provisions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">
<p style="font-family: Times New Roman; font-size: 8pt; font-variant: normal; margin: 0pt 0pt 0pt 8pt;">AUSTIN&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BEIJING&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BOULDER&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BOSTON&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; BRUSSELS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; HONG KONG&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LONDON&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; LOS ANGELES&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NEW YORK&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PALO ALTO<br>
SALT LAKE CITY&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SAN DIEGO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SAN FRANCISCO&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SEATTLE&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SHANGHAI&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; WASHINGTON, DC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; WILMINGTON, DE</p>
</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">
<div><img alt="ws03.jpg" src="ws03.jpg"></div>
</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">On the basis of the foregoing, we are of the opinion that the Shares have been duly authorized by the Company and, when issued and delivered by the Company against payment therefor in accordance with the terms of and in the manner contemplated by the Securities Purchase Agreement and the Registration Statement, will be validly issued, fully paid and nonassessable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We express no opinion as to the laws of any other jurisdiction, other than the federal laws of the United States of America and the General Corporation Law of the State of Delaware.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">We consent to the use of this opinion as an exhibit to the Company&#8217;s Current Report on Form 8-K filed on or about the date hereof, for incorporation by reference into the Registration Statement. In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Times New Roman; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 42%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 58%;">Very truly yours,</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 42%;">&nbsp;</td>
			<td style="vertical-align: top; width: 58%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 42%;">&nbsp;</td>
			<td style="vertical-align: top; width: 58%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 11pt;text-indent:-11pt;">/s/ Wilson Sonsini Goodrich &amp; Rosati, P.C.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: middle; width: 42%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 58%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 42%;">&nbsp;</td>
			<td style="vertical-align: top; width: 58%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">WILSON SONSINI GOODRICH &amp; ROSATI</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 42%;">&nbsp;</td>
			<td style="vertical-align: top; width: 58%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Professional Corporation</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex_536281.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_536281.htm</title>

	<!-- Generated by ThunderDome Portal - 6/21/2023 9:10:23 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin: 0px 0pt; text-align: right; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><i><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></i></p>

<p style="margin: 0px 0pt; text-align: left; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;"><b>FORM OF</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;"><b>SECURITIES PURCHASE AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This Securities Purchase Agreement (this &#8220;<u>Agreement</u>&#8221;) is dated as of June 21, 2023, between BioCardia, Inc., a Delaware corporation (the &#8220;<u>Company</u>&#8221;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &#8220;<u>Purchaser</u>&#8221; and collectively the &#8220;<u>Purchasers</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE I.</b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">DEFINITIONS</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.1 <u>Definitions</u>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Action</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(j).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Board of Directors</u>&#8221; means the board of directors of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Business Day</u>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; <u>provided</u>, <u>however</u>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home,&#8221; &#8220;shelter-in-place,&#8221; &#8220;non-essential employee&#8221; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York are generally open for use by customers on such day.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Closing</u>&#8221; means the closing of the purchase and sale of the Shares pursuant to Section 2.1.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: justify;">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="-" data-startnum="2" data-suffix="-" data-textalign="center">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Closing Date</u>&#8221; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers&#8217; obligations to pay the Subscription Amount and (ii) the Company&#8217;s obligations to deliver the Shares, in each case, have been satisfied or waived, but in no event later than the second (2<sup style="vertical-align:top;line-height:120%;font-size:pt">nd</sup>) Trading Day following the date hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Common Stock</u>&#8221; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Common Stock Equivalents</u>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Company Counsel</u>&#8221; means Wilson Sonsini Goodrich &amp; Rosati, with offices located at 650 Page Mill Road, Palo Alto, California 94304-1050.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Disclosure Schedules</u>&#8221; means the Disclosure Schedules of the Company delivered concurrently herewith.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Disclosure Time</u>&#8221; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>GAAP</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(b).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Liens</u>&#8221; means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Material Adverse Effect</u>&#8221; shall have the meaning assigned to such term in Section 3.1(b).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Per Share Purchase Price</u>&#8221; equals $2.336, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-2-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Person</u>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Placement Agent</u>&#8221; means Titan Partners Group LLC, a division of American Capital Partners, LLC.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Proceeding</u>&#8221; means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or, to the knowledge of the Company, threatened.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Prospectus</u>&#8221; means the final base prospectus filed as part of the Registration Statement, including all information, documents and exhibits filed with or incorporated by reference into such base prospectus.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Prospectus Supplement</u>&#8221; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act, including all information, documents and exhibits filed with or incorporated by reference into such Prospectus Supplement, that is filed with the Commission and delivered by the Company to each Purchaser at the Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Registration Statement</u>&#8221; means the effective registration statement with Commission File No. 333-249426, including all information, documents and exhibits filed with or incorporated by reference into such registration statement, which registers the sale of the Shares to the Purchasers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Required Approvals</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(e).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Rule 424</u>&#8221; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>SEC Reports</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(h).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Shares</u>&#8221; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Short Sales</u>&#8221; means all &#8220;short sales&#8221; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Subscription Amount</u>&#8221; means, as to each Purchaser, the aggregate amount to be paid for Shares purchased hereunder as specified below such Purchaser&#8217;s name on the signature page of this Agreement and next to the heading &#8220;Subscription Amount,&#8221; in United States dollars and in immediately available funds.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-3-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Subsidiary</u>&#8221; means any subsidiary of the Company as set forth in the SEC Reports, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Trading Market</u>&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Transaction Documents</u>&#8221; means this Agreement, all exhibits and schedules hereto, and any other documents or agreements executed in connection with the transactions contemplated hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Transfer Agent</u>&#8221; means Continental Stock Transfer &amp; Trust Company, 1 State Street, 30th Floor, New York, NY 10004, and any successor transfer agent of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE II.</b><br>
PURCHASE AND SALE</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.1 <u>Closing</u>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $2,647,017.37 of Shares. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic transfer of the Closing documentation. At the Closing, the Company shall issue to each Investor, as indicated on the Purchaser&#8217;s respective signature page, such Purchaser&#8217;s Shares in book-entry form, registered in such Purchaser&#8217;s name and address, subject to the Company&#8217;s receipt of the applicable Purchaser&#8217;s Subscription Amount, unless directed by the Placement Agent, in which case the Company shall settle the applicable Purchaser&#8217;s shares via &#8220;Delivery Versus Payment&#8221; (i.e., on the Closing Date, for such Purchasers, the Company shall issue the Shares registered in such Purchasers&#8217; names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each such Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.2 <u>Deliveries</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(a) On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i) this Agreement duly executed by the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-4-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii) a legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers, in a form reasonably acceptable to the Placement Agent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii) the Company shall have provided each Purchaser with the Company&#8217;s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv) a copy of the instructions to the Transfer Agent instructing the Transfer Agent to deliver Shares equal to such Purchaser&#8217;s Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser or, as applicable, via The Depository Trust Company Deposit or Withdrawal at Custodial system; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v) the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(b) On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i) this Agreement duly executed by such Purchaser; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii) such Purchaser&#8217;s Subscription Amount, which may be made available for &#8220;Delivery Versus Payment&#8221; settlement with the Company or its designee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.3 <u>Closing Conditions</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(a) The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (except to the extent a representation or warranty speaks as of a specific date, in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) as of such date);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii) all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii) the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(b) The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i) the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (except to the extent a representation or warranty speaks as of a specific date, in which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-5-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii) all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii) the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv) from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&#8217;s principal Trading Market, and trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of the Placement Agent, makes it impracticable or inadvisable to purchase the Shares at the Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE III.</b><br>
REPRESENTATIONS AND WARRANTIES</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.1 <u>Representations and Warranties of the Company</u>. Except as set forth in the SEC Reports (as defined below) and the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(a) <u>Subsidiaries</u>. All of the direct and indirect significant subsidiaries (as such term is defined in Rule 1-02 of Regulation S-X promulgated by the Commission) of the Company are set forth in the Company&#8217;s SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-6-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(b) <u>Organization and Qualification</u>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not reasonably be expected to result in a Material Adverse Effect and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. For the purposes of this Agreement, a &#8220;<u>Material Adverse Effect</u>&#8221; means (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole or (iii) a material adverse effect on the Company&#8217;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document, provided, however, that, in the case of clause (i), none of the following shall be deemed to constitute, alone or in combination, or be taken into account in the determination of whether, there has been or will be a Material Adverse Effect: (a) any change or proposed change in or change in the interpretation of any law or United States generally accepted accounting principles (&#8220;<u>GAAP</u>&#8221;) after the date of this Agreement; (b) events or conditions generally affecting the industries or geographic areas in which the Company and its subsidiaries operate; (c) any downturn in general economic conditions, including changes in the credit, debt, securities, financial or capital markets (including changes in interest or exchange rates, prices of any security or market index or commodity or any disruption of such markets); (d) acts of war, sabotage, civil unrest or terrorism, or any escalation or worsening of any such acts of war, sabotage, civil unrest or terrorism, or changes in global, national, regional, state or local political or social conditions; (e) any hurricane, tornado, flood, earthquake, natural disaster, or other acts of God; (f) any actions taken or not taken by the Company as required by this Agreement or (g) a change in the market price or trading volume of Common Stock alone.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(c) <u>Authorization; Enforcement</u>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company&#8217;s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-7-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(d) <u>No Conflicts</u>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Shares and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&#8217;s or any Subsidiary&#8217;s certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as would not reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(e) <u>Filings, Consents and Approvals</u>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.3 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s) to each applicable Trading Market for the listing of the Shares for trading thereon in the time and manner required thereby, (iv) such filings as are required to be made under applicable state securities laws and (v) any such consents, waivers, authorizations that have been, or prior to the Closing Date will be, obtained by the Company or as would not have or reasonably be expected to result in a Material Adverse Effect (collectively, the &#8220;<u>Required Approvals</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(f) <u>Issuance of the Shares; Registration</u>. The Shares are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on October 20, 2020, including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus Supplement with the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not as of the most recent effective date thereof contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the transaction requirements as set forth in General Instruction I.B.6 of Form S-3.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-8-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(g) <u>Capitalization</u>. The equity capitalization of the Company as of March 31, 2023 is as set forth in the SEC Reports. Except as set forth in <u>Section 3.1(g)</u>, the Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(h) <u>SEC Reports; Financial Statements</u>. Since January 1, 2022, the Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being collectively referred to herein as the &#8220;<u>SEC Reports</u>&#8221;), and such SEC Reports have been filed on a timely basis or the Company has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and the SEC Reports taken as a whole, as of the date hereof, do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP, except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-9-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(i) <u>Material Changes; Undisclosed Events, Liabilities or Developments</u>. Since the date of the latest audited or reviewed financial statements included within the SEC Reports, except as disclosed in a subsequent SEC Report filed prior to the date hereof or set forth on <u>Schedule 3.1(i)</u>, (i) there has not been a Material Adverse Effect, (ii) the Company has not incurred any material liabilities (contingent or otherwise) other than liabilities not required to be reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the SEC, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(j) <u>Litigation</u>. Except as set forth in <u>Schedule 3.1(j)</u>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an &#8220;<u>Action</u>&#8221;). None of the Actions set forth on <u>Schedule 3.1(j)</u>, (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Shares or (ii) would, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(k) <u>Compliance</u>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as would not have or reasonably be expected to result in a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(l) <u>Title to Real and Personal Property</u>. The Company and its Subsidiaries have good and marketable title in fee simple to all items of real property owned by them, good and valid title to all personal property described in the Registration Statement or Prospectus as being owned by them, in each case free and clear of all liens, encumbrances and claims, except those matters that (i) do not materially interfere with the use made and proposed to be made of such property by the Company and any of its Subsidiaries or (ii) would not, individually or in the aggregate, have a Material Adverse Effect. Any real or personal property described in the Registration Statement or Prospectus as being leased by the Company and any of its Subsidiaries is held by them under valid, existing and enforceable leases, except those that (A) do not materially interfere with the use made or proposed to be made of such property by the Company or any of its Subsidiaries or (B) would not be reasonably expected, individually or in the aggregate, to have a Material Adverse Effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-10-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(m) <u>Insurance</u>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as the Company reasonably believes are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(n) <u>Transactions With Affiliates and Employees</u>. Except as disclosed in the SEC Reports, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company, (iii) purchases of Common Stock by certain directors and executive officers in the Company&#8217;s private placement of common stock in December 2022 and (iv) other employee benefits, including stock option agreements under any stock option plan of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(o) <u>Sarbanes-Oxley; Internal Accounting Controls</u>. There is and has been no failure on the part of the Company or any of the Company&#8217;s directors or officers, in their capacities as such, to comply in all material respects with any applicable provisions of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder. Each of the principal executive officer and the principal financial officer of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the Commission. For purposes of the preceding sentence, &#8220;principal executive officer&#8221; and &#8220;principal financial officer&#8221; shall have the meanings given to such terms in the Sarbanes-Oxley Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(p) <u>Investment Company</u>. The Company is not and immediately after receipt of payment for the Securities, will not be, required to register as an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(q) <u>Listing and Maintenance Requirements</u>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as set forth on Schedule 3.1(q), the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-11-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(r) <u>Foreign Corrupt Practices</u>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(s) <u>Office of Foreign Assets Control</u>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent or employee of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;OFAC&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(t) <u>Money Laundering</u>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &#8220;Money Laundering Laws&#8221;), except where the failure to be in such compliance would not result in a Material Adverse Effect, and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(t) <u>Certain Fees</u>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-12-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.2 <u>Representations and Warranties of the Purchasers</u>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(a) <u>Organization; Authority</u>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(b) <u>Understandings or Arrangements</u>. Such Purchaser is acquiring the Shares as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Shares (this representation and warranty not limiting such Purchaser&#8217;s right to sell the Shares pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Shares hereunder in the ordinary course of its business. Such Purchaser is acquiring such Shares as principal for his, her or its own account and not with a view to or for distributing or reselling such Shares or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Shares in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Shares in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser&#8217;s right to sell such Shares pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(c) <u>Purchaser Status</u>. At the time such Purchaser was offered the Shares, it was, and as of the date hereof it is, either: an &#8220;accredited investor&#8221; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a &#8220;qualified institutional buyer&#8221; as defined in Rule 144A(a) under the Securities Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(d) <u>Experience of Such Purchaser</u>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Shares, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Shares and, at the present time, is able to afford a complete loss of such investment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-13-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(e) <u>Access to Information</u>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Shares and the merits and risks of investing in the Shares; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Shares nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Shares and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Shares to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(f) <u>Certain Transactions and Confidentiality</u>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Placement Agent, the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&#8217;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser&#8217;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Shares covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser&#8217;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 18pt; text-align: justify;">The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&#8217;s right to rely on the Company&#8217;s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-14-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE IV.</b><br>
OTHER AGREEMENTS OF THE PARTIES</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.1 <u>Furnishing of Information</u>. Until the earlier of (i) the second anniversary of the Closing Date and (ii) the time that no Purchaser owns Shares, the Company covenants to use commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act so long as the Company is then subject to the reporting requirements of the Exchange Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.2 <u>Integration</u>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Shares for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.3 <u>Securities Laws Disclosure; Publicity</u>. The Company shall file with the Commission on or before the Closing Date a Current Report on Form 8-K, including the required Transaction Documents as exhibits thereto. From and after the date of such filing, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its officers, directors, employees or Affiliates in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the date of such filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company or any of its officers, directors, employees or Affiliates on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market or FINRA regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.4 <u>Reservation of Common Stock</u>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-15-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.5 <u>Certain Transactions and Confidentiality</u>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company&#8217;s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.3. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company in accordance with Section 4.3, such Purchaser will maintain the confidentiality of the existence and terms of this transaction (other than as disclosed to its legal and other representatives).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.6 <u>Use of Proceeds</u>. Except as set forth on Schedule 4.6 attached hereto, the Company shall use the net proceeds from the sale of the Shares hereunder for working capital and other general corporate purposes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.7 <u>Indemnification of Purchasers</u>. Subject to the provisions of this Section 4.7, the Company will indemnify and hold each Purchaser and its directors, officers, employees and Affiliates (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a &#8220;<u>Purchaser Party</u>&#8221;) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys&#8217; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a material breach of such Purchaser Party&#8217;s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence, willful misconduct or malfeasance). The Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&#8217; fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ one separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party effected without the Company&#8217;s prior written consent, which shall not be unreasonably withheld or delayed; or (2) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&#8217;s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.7 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-16-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.8 <u>Listing of Common Stock</u>. The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common Stock on a Trading Market through the second anniversary of the Closing date so long as the Company is then subject to the reporting requirements of the Exchange Act, and prior to the Closing, the Company shall have applied to list or quote all of the Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares, and will take such other action as is necessary to cause all of the Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#8217;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. For so long as the Company maintains a listing or quotation of the Common Stock on a Trading Market, the Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.9 <u>Equal Treatment of Purchasers</u>. No consideration (including any modification of this Agreement) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered to all of the parties to this Agreement. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-17-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>ARTICLE V.</b><br>
MISCELLANEOUS</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.1 <u>Termination</u>. This Agreement may be terminated by any Purchaser, as to such Purchaser&#8217;s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>) Trading Day following the date hereof; <u>provided</u>, <u>however</u>, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.2 <u>Fees and Expenses</u>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company), stamp taxes and other taxes and duties levied in connection with the delivery of any Shares to the Purchasers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.3 <u>Entire Agreement</u>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.4 <u>Notices</u>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<sup style="vertical-align:top;line-height:120%;font-size:pt">nd</sup>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.5 <u>Amendments; Waivers</u>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Shares and the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-18-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.6 <u>Headings</u>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.7 <u>Successors and Assigns</u>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Shares, provided that such transferee agrees in writing to be bound, with respect to the transferred Shares, by the provisions of the Transaction Documents that apply to the &#8220;Purchasers.&#8221;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.8 <u>No Third-Party Beneficiaries</u>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in this Section 5.8.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.9 <u>Governing Law</u>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-19-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.10 <u>Survival</u>. The representations and warranties contained herein shall survive the Closing and the delivery of the Shares through the second anniversary of the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.11 <u>Execution</u>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such &#8220;.pdf&#8221; signature page were an original thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.12 <u>Severability</u>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.13 <u>Rescission and Withdrawal Right</u>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.14 <u>Remedies</u>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-20-</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.15 <u>Independent Nature of Purchasers</u><u>&#8217;</u><u> Obligations and Rights</u>. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents or has freely elected not to be represented by counsel after having been advised of the desirability to engage such counsel. For reasons of administrative convenience only, a Purchaser and its counsel may have chosen to communicate with the Company through the legal counsel of the Placement Agent. The legal counsel of the Placement Agent does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.16 <u>Saturdays, Sundays, Holidays, etc.</u> If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.17 <u>Construction</u>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.18 <b><u>WAIVER OF JURY TRIAL</u></b><b>. </b><b><u>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><i>(Signature Pages Follow)</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="21" data-prefix="-" data-suffix="-" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">-21-</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td colspan="3" style="vertical-align: top; width: 47%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>BIOCARDIA, INC.</b></p>
			</td>
			<td style="vertical-align: top; width: 48%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><u>Address for Notice:</u></p>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align: top; width: 47%;">&nbsp;</td>
			<td style="vertical-align: top; width: 48%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">By:</p>
			</td>
			<td style="border-bottom: 3px solid rgb(0, 0, 0); vertical-align: top; width: 40%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 48%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">320 Soquel Way</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 7%;">&nbsp;</td>
			<td style="vertical-align: top; width: 40%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 48%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Name:</p>
			</td>
			<td style="vertical-align: top; width: 40%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Peter Altman, Ph.D.</p>
			</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 48%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Sunnyvale, CA 94085</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 7%;">&nbsp;</td>
			<td style="vertical-align: top; width: 40%;">&nbsp;</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 48%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Title:</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 40%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Chief Executive Officer</p>
			</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 48%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 7%; padding: 0pt; text-indent: 36pt; text-align: justify;">Email:</td>
			<td style="vertical-align: top; width: 40%; padding: 0pt; text-indent: 36pt; text-align: justify;">paltman@biocardia.com</td>
			<td style="vertical-align: top; width: 5%;">&nbsp;</td>
			<td style="vertical-align: top; width: 48%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:25.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">With a copy to (which shall not constitute notice):</p>
			</td>
			<td style="vertical-align:top;width:25.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Wilson Sonsini Goodrich &amp; Rosati</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">650 Page Mill Road</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Palo Alto, California 94304-1050</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Attn: Michael Danaher</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Email: mdanaher@wsgr.com</p>
			</td>
			<td style="vertical-align:top;width:auto;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="22" data-prefix="-" data-suffix="-" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">-22-</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Name of Purchaser: _________________________________________________________________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><i>Signature of Authorized Signatory of Purchaser</i>: __________________________________________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Name of Authorized Signatory: ________________________________________________________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Title of Authorized Signatory: _________________________________________________________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Email Address of Authorized Signatory:__________________________________________________________________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Address for Notice to Purchaser:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Address for Delivery of Shares to Purchaser (if not same as address for notice):</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Subscription Amount: $_________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Shares: _________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">EIN Number: _______________________</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[SIGNATURE PAGES CONTINUE]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#9744; Notwithstanding anything contained in this Agreement to the contrary, if this signature page is accepted and agreed to by the Company, by checking this box (i) the obligations of the above-signed to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur by the second (2nd) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="-" data-suffix="-" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">-23-</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bcda-20230621.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/21/2023 9:12:43 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:bcda="http://www.bcda.com/20230621" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bcda.com/20230621">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcda-20230621_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcda-20230621_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bcda-20230621_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.bcda.com/20230621/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="bcda_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bcda_CommonStockParValue0001CustomMember" name="CommonStockParValue0001CustomMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="bcda_WarrantToPurchaseCommonStockCustomMember" name="WarrantToPurchaseCommonStockCustomMember" nillable="true" substitutionGroup="xbrli:item" type="dtr-types:domainItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>bcda-20230621_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/21/2023 9:12:43 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.bcda.com/20230621/role/statement-document-and-entity-information" xlink:href="bcda-20230621.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.bcda.com/20230621/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain-default" xlink:type="locator"/>
<link:loc xlink:href="bcda-20230621.xsd#bcda_CommonStockParValue0001CustomMember" xlink:label="bcda_CommonStockParValue0001CustomMember" xlink:type="locator"/>
<link:loc xlink:href="bcda-20230621.xsd#bcda_WarrantToPurchaseCommonStockCustomMember" xlink:label="bcda_WarrantToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bcda_CommonStockParValue0001CustomMember" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="bcda_WarrantToPurchaseCommonStockCustomMember" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bcda-20230621_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/21/2023 9:12:43 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:label xlink:label="us-gaap_StatementClassOfStockAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:label xlink:label="us-gaap_ClassOfStockDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain-label" xlink:type="arc"/>

<link:loc xlink:href="bcda-20230621.xsd#bcda_CommonStockParValue0001CustomMember" xlink:label="bcda_CommonStockParValue0001CustomMember" xlink:type="locator"/>
<link:label xlink:label="bcda_CommonStockParValue0001CustomMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CommonStockParValue0001 Custom [Member]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bcda_CommonStockParValue0001CustomMember" xlink:to="bcda_CommonStockParValue0001CustomMember-label" xlink:type="arc"/>

<link:loc xlink:href="bcda-20230621.xsd#bcda_WarrantToPurchaseCommonStockCustomMember" xlink:label="bcda_WarrantToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:label xlink:label="bcda_WarrantToPurchaseCommonStockCustomMember-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">WarrantToPurchaseCommonStock Custom [Member]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bcda_WarrantToPurchaseCommonStockCustomMember" xlink:to="bcda_WarrantToPurchaseCommonStockCustomMember-label" xlink:type="arc"/>


</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bcda-20230621_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 6/21/2023 9:12:43 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.bcda.com/20230621/role/statement-document-and-entity-information" xlink:href="bcda-20230621.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.bcda.com/20230621/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" xlink:type="locator"/>
<link:loc xlink:href="bcda-20230621.xsd#bcda_CommonStockParValue0001CustomMember" xlink:label="bcda_CommonStockParValue0001CustomMember" xlink:type="locator"/>
<link:loc xlink:href="bcda-20230621.xsd#bcda_WarrantToPurchaseCommonStockCustomMember" xlink:label="bcda_WarrantToPurchaseCommonStockCustomMember" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="bcda_CommonStockParValue0001CustomMember" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="bcda_WarrantToPurchaseCommonStockCustomMember" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" xlink:type="arc"/>

<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ws01.jpg
<TEXT>
begin 644 ws01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M?S7\O2CV;<.9#==*K[-GN/VNV-S]G%Q%Y_\ SRWC=Z].M35X3;?\G;-_NO\
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M^'>E^%/$FIZU87-W+<:D6,J3,I1=S[SMPH/7U)K.,DHM&]2#E.+70X']I/\
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' %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ws03.jpg
<TEXT>
begin 644 ws03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 X17AI9@  34T *@    @  @$2  ,
M   !  $   $Q  (    *    )@    !'<F5E;G-H;W0 _]L 0P " 0$" 0$"
M @(" @(" @,% P,# P,&! 0#!0<&!P<'!@<'" D+"0@("@@'!PH-"@H+# P,
M# <)#@\-# X+# P,_]L 0P$" @(# P,& P,&# @'" P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ (@!+
M P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*"__$
M +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"
ML<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=8
M65IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JR
ML[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY
M^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$
M P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)R
MT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H
M:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BY
MNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "
M$0,1 #\ _7SXR_ME7/P3_;E^$/PIU3PW;MX;^,%EJB:;XD&H%6M-4L8Q,;.2
M Q[=LD)!1_-!+@J$[U\S_#7_ (."O"GQ'_9G_:0^(T/A-8X_@;J"PZ/9KJY8
M^+;6ZG>VTV?=Y(,'VB:,J5590@((+5[1_P %A?V-/%G[9G[*5M9?#FZM],^*
M/@O7K+Q+X2O9;K[(L-U$6AE4S8.T-;33XR""RIGU'S3XM_X(5ZII_P :?V7X
M_#U_IL/P[\$:!I6C?$RU\_REUU])N#J%M)Y6W]]]HO)9P^2NU2#R,"NZC'#N
M%ZF_^6OX[?B>+BYXZ-5J@KQ_ST_\E?O/R=CZR^+_ .VUKWP2\4?LWZ#K7@FS
M36_CAJZ:+K$"ZLQ7PQ/]@-U*(V\G_2=CJ8^1%D#=Q]VMKX8?MAS_ !"_;Y^*
M'P4;P[#:6_P[T#2-:361?F1]0-]YF8S!Y8$8CV?>WMNST%<[^W)^S'XM^.G[
M27[-/B;P];V,VD_#/QM/KFO//="&2&V>QEA4QJ1^\;>P&T<_KCRWQY\&OVA/
M@;_P4G^*GQ>^&GPV\$_$+P]\0/#>BZ-%'JWC0Z%-:262R;V*BUGW!F? ^[TS
MDYK&,:;CI:]GUZW_ ,CHG4KPGU:4DM%?3EUV\SMOVU?V_?&7PA_:G\!_!/X8
M^#_"/B+QYXVT>Z\0)<^+?$9T32UMX)!']FA9(I)+BZD;=B-0-J@,<KN*]M\=
M?VWF_9,_8P@^*7Q0\(76A^(FM[6WD\':7?QZK=R:K<NL4.G03JJI,[2,!O "
M@!FY"\^5?\%./V??B!^TA:^'M,_X9[^#GQT\%MIKK=:=KOB2;1->T+4Y2-TU
MI?"(A+<(JJWE%)7(Z@#!R+3_ ()?^/O%O_!)CP/\&O$_Q CF^+7@.ZM?$>B^
M))7FU"ST[5+2]>ZLX&:0"6:WB1A;;F&X(-P7A5JXQH\L6WU5^_KY?<3*IB?:
M5%!-Z.VEDGI9;:O?6_R1>M/^"D?QF^!GQ*\"0?M!? C1_AYX'^)>L6_A_3]=
MT/QA'KK>'M1N<BVM-1C$,8 D8;?/B8QJ1SG/&M^T5_P5\\-_LK_\%+/"/P%\
M::+'I7A_QAH=K?6_C!]0_<V5_<W%Q#!:SP^7A(G:#;Y_F':TB[E"!I%Y+X@_
M 7]I/_@H)XB\ >%_C'X/^&_PM^'G@CQ)8^)]?GT+Q++KEYXSN;%O,@@M8V@B
M%I:-+AG\UFE "@'@YW?VC/\ @F7_ ,-<_M\>/M<\>:78:A\(_&_P@M_!$ACO
M-NH0:G'JQO$FCC*D*T0VR)(20'4 J03FX^P7\3L]G]S,7+&<MJ3?Q+62L[6U
MNM-+Z7MU/8OV2/VOYOVE_BG\;O#LWAV'0U^$?C$^%HKA+XW!U91;QR^>RF-?
M*/[PC8"_3.[FO>%.5%?$G_!&/]A[XH?L/>'OBYIOQ2URU\4ZGXD\5I>Z?KD=
MT9IM9M(K2*WCN)E/S1RLL2Y5BQ!SEF^\?ML=*YZT8QFU#5'?@9U945*LK2UN
MNVK/@'_@K_\ $3XD^ OBU\-6D\1_&#P+^STUC?R^,/$OPPTQ+S6M-U!=AM3=
MMY4TL-BJ[V+QQL&.Y6!)C(T/C)^V?K7@?_@GI\&;KX4_$W3?B=XJ^,7B;2/A
M[HOQ'U33(A;Q75[)*DNI3V<:HGF1""5! R@B54$@<APWM_[5/[&GB#]H7QEH
MOB3PK\;OBG\)=:T>RETYH_#UU;S:9?P2N'<S6=Q')&TX*@+,,,HXYXQD:%_P
M2I^$^D_L)6?[/<UOK>H^#+)FO(M1N+XKK4>HFY:[&I)<H%\NZ%PQD#(H4?<V
M>62ATC4I<L>;=?EKJ[G)4H5W4J.GIS+1W]-NRWZ770\5^*UW\7/^"9GQF^"^
MJZE\:O%OQH\#_%3QI9> O$6B^*]/L%N[.\OUD\B_TZ6T@A,21O$=\#"12A.,
M'#+YO\9_^"GGQ%_9&_X*\_$Z'Q3-?:U^S7X=D\-:'X@(AC=? T^IV*26VH#:
MOF>2T\<RRY++B08^?RT?Z4^$O_!*VQ\-_&SPQX]^(WQ:^*7QMUCP 7;PC;>+
MKRV-CH4K+L^U"&WAB$]V$R//EW$9# !E5AW5O_P3Y\%W?QI^-_BW76N?$UG\
M?--TO2?$6AZ@D;6$5O8VLELHBV@."ZR$DEB0P!4KBM8UJ7VU?2VUNJ^ZR\C&
M6%Q4E^[?+[R:N[V2BUKW3?0^3?@S^T;\??CG_P $L?V@_$?PWU^Z\9?%+2?B
M#X@TOPK>1K;7$R:;!?PJ%M 0(I72T,IASG>VW!8D9]&_X)5_%OP_XCM?B%HN
ME_'?XR_$/7M)M+>>^\(?%+2UL/$_@R<I)YK2![>*5TD8H %+Q1[ H8LQ)[/X
M#_\ !)7PO^SI^Q%KWP+\+?$+XG:+H^L:Q+K5OXATS5DT_7M+E:2&1%AN(8U7
M:IA4$,AW@L#UXW?V4O\ @G7#^SY\4/%'Q \4?$?QS\6/B-XHT>+P[)X@\1-;
MQ&QTR)VD2VMX+>-(T!D;>S$,689^7+;HJ5*3YDMKZ:>A5+#8A2IRENE9ZZ+?
M;S^^_E8^(O%G[:/QTU'_ (($_!'XA^'/'NI1_%[QAXOM=(?7)DMA)?&75;ZV
MCBEWQ^5L(2%3E0,*,]\^A_ G_@JAXB_:P_;3_9=\,Q75UX)UV:3QGH?Q7\"E
M%5K+5M.T^%XA(K@N(?-\R6%@V#\ZDLT;@>]Z=_P21\(:=^PU\-_@0OBKQ4V@
M?#3Q%:>([+4R+?[==S6]_+?+')^[V;"\K*=J@[0,'.2>E\4?\$QOA_KW_!0W
MPS^TI9R:EHWCK0[&XLKZWM/*6QU[S+62U2:X4H6\V.*0J'5AN5(PV0@K25:A
M9IK^:S]=OZZ&4<'C4X2YMO9IIOM9R:\]+>:9SO\ P3S^-GBSXI_M+?M5:/XB
MUV\U;2_!/Q#CTK0K>8($TRU-C!(84VJ#MWLQ^8DY/6OK(=*\@_9W_9%T?]G+
MXG?%CQ1INL:MJ5U\6_$:^)+^"[$?EV$JP)#Y<.U0=F$!^8DY/6O7P,"N.I*+
IE>.VGY(]?#1G&GRSWU_/_(,4445F= 8HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139968190945328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 21, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">BIOCARDIA, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Jun. 21,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">0-21419<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">23-2753988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">320 Soquel Way<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Sunnyvale<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">94085<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">226-0120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000925741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bcda_CommonStockParValue0001CustomMember', window );">CommonStockParValue0001 Custom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BCDA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bcda_WarrantToPurchaseCommonStockCustomMember', window );">WarrantToPurchaseCommonStock Custom [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrant to Purchase Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BCDAW<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bcda_CommonStockParValue0001CustomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bcda_CommonStockParValue0001CustomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bcda_WarrantToPurchaseCommonStockCustomMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bcda_WarrantToPurchaseCommonStockCustomMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>bcda20230621_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bcda="http://www.bcda.com/20230621"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bcda-20230621.xsd" xlink:type="simple"/>
    <context id="d20238K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000925741</identifier>
        </entity>
        <period>
            <startDate>2023-06-21</startDate>
            <endDate>2023-06-21</endDate>
        </period>
    </context>
    <context id="d20238K_StatementClassOfStockAxis_CommonStockParValue0001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000925741</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bcda:CommonStockParValue0001CustomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-21</startDate>
            <endDate>2023-06-21</endDate>
        </period>
    </context>
    <context id="d20238K_StatementClassOfStockAxis_WarrantToPurchaseCommonStock">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000925741</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bcda:WarrantToPurchaseCommonStockCustomMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-21</startDate>
            <endDate>2023-06-21</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20238K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20238K">0000925741</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20238K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20238K">2023-06-21</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20238K">BIOCARDIA, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20238K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20238K">0-21419</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20238K">23-2753988</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20238K">320 Soquel Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20238K">Sunnyvale</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20238K">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20238K">94085</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20238K">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20238K">226-0120</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d20238K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20238K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20238K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20238K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001">BCDA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K_StatementClassOfStockAxis_CommonStockParValue0001">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="d20238K_StatementClassOfStockAxis_WarrantToPurchaseCommonStock">Warrant to Purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20238K_StatementClassOfStockAxis_WarrantToPurchaseCommonStock">BCDAW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20238K_StatementClassOfStockAxis_WarrantToPurchaseCommonStock">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d20238K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M6H&+6W@6Q2&LEHZCX +MEH.!%,;OXL[]1?DP)].UDIAG5(A0VCYS7(H2%4W
MQ:W[40MCN(2)B:)4[BTC*:7"A98L3- T+[S?Q>UYID+A"R/DBMQ"?FO!PE(>
M7*62IS!Z%S?IJ>9G/DP/AP++ED!S+@.NR?UR>21^N%XE6>'Y+N[0/Y!-DB0%
MLDI 7+82L#!]]S37OXZX7MF ?@()L[;9%C.Y+67#%:O8:.'U%/?F(<Q8D,W:
M3<A6I<M77* 2I3!V>IJQCX!&@T%,('POY#,OG: *+0?^NK1UT70QM(-E/V["
MUA>4G!GE/TV9_LK"E,,-7#+*WHG(MUMN7:Q\]?\1RW]:F#[U/N"-!>T#[V4N
M^@/%K7TN#*PFU9*X]-?%;V3&_13\N3P-<*5=W$@6N#J)F2;/-G;D9^<<PH?!
M%JV#XHX_URRP-3W;1@M5:M$5 E>C,;;XH$7'H!4=8S]/Y/K%7S.YXD=?]2J$
M[H:S\? OC*GH&A1W^4>F[4OG7$U3#5!VPR*OI).J!Y5_;R86K85V/J!ZT+[R
M7N:BVU"\-[RE>G"E??"(4>0U?.2PHK#]B:(!>7C_J*Z?"@%;/X\82M& /+QI
MG%Y %4+'"ZAQL#EF-QIOF5T1)"3D2U!RSB_ *_1N[VYW8E2<[9<ME(%:R0[7
MG,&ZQEX OR^5,J\G=@LNWT$=_ =02P,$%     @ \(K55I^@&_"Q @  X@P
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( /"*U58'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ \(K55F6V&[;N    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ \(K55IE<G",0!@  G"<  !,
M     ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #PBM56
M"LQQT],$  !-%0  &               @($-"   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ \(K55I^@&_"Q @  X@P   T
M     ( !%@T  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #PBM56EXJ[',
M   3 @  "P              @ 'R#P  7W)E;',O+G)E;'-02P$"% ,4
M" #PBM56.JJBYT !   \ @  #P              @ ';$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ \(K55B0>FZ*M    ^ $  !H
M ( !2!(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M\(K55F60>9(9 0  SP,  !,              ( !+1,  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  =Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bcda20230621_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bcda.com/20230621/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bcda20230621_8k.htm">bcda20230621_8k.htm</File>
    <File>bcda-20230621.xsd</File>
    <File>bcda-20230621_def.xml</File>
    <File>bcda-20230621_lab.xml</File>
    <File>bcda-20230621_pre.xml</File>
    <File>ex_536281.htm</File>
    <File>ex_536556.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bcda20230621_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "bcda-20230621_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bcda20230621_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bcda-20230621_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bcda-20230621_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bcda-20230621.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "bcda",
   "nsuri": "http://www.bcda.com/20230621",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "bcda20230621_8k.htm",
      "contextRef": "d20238K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.bcda.com/20230621/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "bcda20230621_8k.htm",
      "contextRef": "d20238K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "bcda_CommonStockParValue0001CustomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CommonStockParValue0001 Custom [Member]"
       }
      }
     },
     "localname": "CommonStockParValue0001CustomMember",
     "nsuri": "http://www.bcda.com/20230621",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "bcda_WarrantToPurchaseCommonStockCustomMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WarrantToPurchaseCommonStock Custom [Member]"
       }
      }
     },
     "localname": "WarrantToPurchaseCommonStockCustomMember",
     "nsuri": "http://www.bcda.com/20230621",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "presentation": [
      "http://www.bcda.com/20230621/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001437749-23-018015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-23-018015-xbrl.zip
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MKR?+5<F$_(]C_(MIS:2]5[=.\RV6_EXD0X$>@?^QT=+=?RM._P502P,$%
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MS2T;H/239$%H)5RTFYP&S5%:Z^BD%?QO"-+[K.:HP$ SHPWQ%GR@6W6ZXU'
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M[JH1_-KX+9Z)Y;&!:FO/,7XA^' 4OZEHQQG\:W1>#P^4@&=\=).1S5RM?J#
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MF3$V<'LQY'[L'7WEGL2-%_ [X1WY& 2N0.?D+1T#Q'H!;IF .4U_8@7Q2L5
ML[66 VLY\$/E0!>X7F^L+"<'R(:YVF<69 ON)TCFXQV@ZW2H0@7OUE)F%82#
M :>UE%E+F8=(F>:NO8R4.8ECHIEMU++PJ*N#F(6TI[[96*#CP!_.;3?H0WCI
M?H..BT_-WI<*UM)D%01B-S9?5=CHM3)R-X"5D@LZ9.04XT/4Y#L<446)SIO8
MP ]4N6Z<'Q%K^U/]:52"WT8E;OPYCG>UA4RVZG,0/VNZL]6TUJG,KSB5>8G/
M=YU^/.M<_=Y;[@MB+V6/[J*0WR7PZZHBWIY;[BQ.M>R$AQMY4^+0"$]EZ'U1
M\XTA' ;WT '.4!"8W=H^&U%OD.R:Z[M+X@IH%D28$*V[HY$:!0+6YC[_%ND+
MNO7C;A6YY*WMS]A1O-7S;%?K+/J*T#+GHE\B?!]VE_3/AS?\?EB;%#X>]D#;
M]5GO<OHP;3_<R"YLA.:.#3]L _.QRZG+.KE@H"9)QU/0095<C&I'B\W*%\]
MSTHL>*"YO8;O#X.OOFH! "R8U%FY.C#1'7$V  ,G.1MS;L[&_.R>TN?.Y94U
M\S]*?9]%/DVKZ-,D \ O\=)&:NP=_C]02P,$%     @ \(K55D-X<NT]70
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MTA+OM-7(C*'BC8E>56<%ESTP?%2<+&=-'XO2%(L IPV']<NL-%7)"DSN]V,
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M>ZVK )#][87\T+>#OQ$:5?IG+=?[L+HB\E_E:.42"$TN9K]QR) X+"I,!>*
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MY;+PB+@)NF^A(>@DAM[3=B)]68QSABXY)3Q'*ML/N'.-%Y,,-*EO,8H=>9X
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M(>8FYDSH/BF4]3M5^5V4M_Q%BO@N>WFG1$SC;X3JMK)S2P=WARJ]OVG-#'5
MAPZN@]/RAR9R<WE97#^5U08S>[5N_:;9XNR4N^W/[0H%<&\K>DOI\PAO#Q:_
M[?8J5  W;U>J>_MT7?AV7?CVJ[L8!W0QOM,U!,EX/'18]V;1_9@,#8B\=;P3
M5-#%0M]8#\,$4D/F8R&E926.:1V \C#V5:>XH8)YZB!8(\$6WB,FFSRI':RC
M0P#$)*#<W0VR8&M/Z]1:(+,*TA:S@!0["=9O00>+$'NH[ZO9Z%(;+\[I=#?@
M+8[3VRH);JZ\5.XV%5P,9^37[ %DL@>*+DD^T/*&]:SV-@%,,JG;T8(-@9/,
M(XV0^LLD(U2:O<F4FL,Y[KY0W#]TS[6BJ'>C7#Y.CUW#=1<T')K2V.Q7QQ39
MH@+(S7H=%.2S[MIGZ\8].SF?;UR_QQG4/=6',/&A;LWO= 37-\^M-\^0;AXG
M3% :SN2NT?6..BKC#9F_HTSJ$,H:QZC%P5=QQSS7ACMILK%8=4\5 A<$$6E*
MY-)$7V_E -T-\JY0E4#8$U23Z<G.+IB3&[O(M0+_W9/_[LM_OR.8)_[K^\W%
MM.*&7R Q?2#B$*'*9467N48&LWFVK#>[CQ\?HG6[Z$WKG7C[3N2BZ<<?D4HW
MD\H'_DT7TH!BZQ\H* FR[M"NYZTOTZYQEXXEJ46'Z)MJ.D8/@=)X,]<76&AS
M_[(OR\8Q#&U&0VS/'"G$])D!%U7/P$::.83O!!IL=?:P37BH+&>;BG28? ,Y
M7>;J:2K3KAR_4+,T0-=64&V04D,#Y PA$"PH^=4$RS! *TP!M+ [G)LJ:%ES
M)Z.LB'738!:!/H,<42C),Y #F$ =ZM^].R)?161A_PM'%O;7D84'%%GXC56U
M#X>4Y0MBXJ2T;M2@G0L+;$2U,!3E3)HW3E@"5E,$F\Q*\9(R=_$2CZ"J"H_^
M/UOM@[1)DP/'1DQ;;3JR!55IP,O*9#G'B<6;H1XE(%!)Y/TZ0W0C154:,PIA
MM'5>2";%DWPERH" /YL;O&@X$;USIW61%R#'AUE=FFN'77GBQ4ES#V=$:ER_
M(K49<>AJ$9Y3^(UW(QR(-F57-7>K"A<"NI)#P"9WE]K.Q6'V_=A>PK%B[(NQ
M,G9RY:I?FLL4+WG"G8HK-2OI5N(T1'.!BE/?7$,'RB$66$6IX<YD'REWEI+A
MW4![&2138@QI#'RU%&L]L\QYL](2A% >2L6X'P'LRG9O B4KZ7:62H_JFC9$
MHD$LQ!*-P#MDI,%C1KB<MU)!(3N $@N)M+09-D+8>9 +#2.%0I;V3 IC&^O)
MQ(933-T/CD6V:LD4!*)0A'ZL#E9-V5M@:?CHSMN'9+-Q"0K\@:9HWK.7FV[X
M45(3#25A^)!UWVX(P]S;;0%CV3Q4E7IK.AN .>P-.C1/MH8EQ1(Z\RZ+7&:9
MY>JR2T0I;=L@G8,0DCQ8Y]NFS"H=?97-(VXN1;U"I!,,:<381Q [-,K3V= @
MC3J!E7NG4=Z_>WCD <P\^";NP:.J'"&#.S)^V!#MV]82<=C0H[UH%L;GK)LS
M[FY FQ=HTAAQ-YPMSJS@?''G2RKGOIM-Y8VI+1A.M'#!,Y+4CLJC1D:1S"/+
MN!BC8+[@CV7+*Y=3YP9.9];1R\5A"$X'QJ1?&$\J 2=M=U9&>2UE\J3:%M[A
M43/.LC;:N(%WMEG)S+%)L<FY$$&L7P">Y^'EK #KXD2;K&V%Z$;.N\U!8'7B
MUI"L'R<6W*A.Z.Z4_3)Q8_84(>EWBTMIUY4@N:9R6Z^L3J(FSUR9231!*I@M
M5A"\2_(Z V$(]^V-P$\:Q+@3U0J,=U05>25J1=W(/_Q'C JUP ^:,*S>4D_T
M&S4X0G$<]T"T@0O=0087M$G_H /#_N55^\G;I'.7N<Q>T-V@KXR!J<J"?<EA
MW+"\DA:$I\#,_:)>&\!BFBT:ME?205TTP^K:Y3;HNNF>C&JK#J#2\EQUBJWS
M5ESDU^[ZD*Q<B ,,R#&'5RRQBN5;<:""F&/F*KHLMQHZ1QUC%J%?>1^YFS$H
M0BG_."&W)!T+7W0;2EA)AYKA_/&<5Q)Z[]_P,#N:!FRC6R 1<TOP^J=-[D2"
M_[/-6\^Q86](KJL\-?I$6LT&="6T8\X2-F.3<G6\&14>(>EN7\3>2N0B9H[3
MC"K6<#!D* 9%=P\C-;4)<CEJK\8&6VQ9/,D75Y>"!H)X0E$$U6B&[.8/2"OI
M*"*[WR_NT*6V"Y>9(7TYU:C-T<5"(YR1=PKQX58IO"WF]!.Z#'D-;PMEU7A7
M56&"KFY?5, LST)=.^R2V=^E!7=[!^%"WOV>JD\5.[Y2>*BHKP,&+9(!OH1D
MT2):GXLY+M<"!O.U%+CG4N"K\'8__L+>[L=K;_<#\G;[;Y9=\^CYL\'SP_/+
MDZ,WQ]')?\+!'L G]?._OKW\Z?@\.GQ]?GS\\_'IY47T]E4$'T5G^/#QQ;T3
M /<A_>#Q]B[Q/'@DKKW8P#NX&1G?E25UD3,ZV+C=&XQAXNU6XK4FSO1^DH!X
M>3<[1CC88PIS? -BV\1>?>_Z-1+],%TK\NB3:5\/F6N_Y\QEGR#7U49^/&(3
M$$^RK6I-%X17/UBR'.@7BH1,06"N:C#VQ;VPJ7G\5JJVSG1J77Q&%ROG$4TU
M>#6R_T*WE$OA6Y6/+GK:D@1BW?#]NP[OQVG88\:\-KNJU?[7RK+3;A%P%7,T
MASEODX)\U5@&>9BW_ TC%&9S'VA5@A+6DIM9[4%3+H@]7/-HP\>]&!5[+XPZ
MV^3SQ G2E#S-@Y""H2[R%-FN>D[D48 5<F$I[@ ?&),V2J#05,?BL(OB(L;#
M5%?7Q/:L7%%#D13&;2+4PTKEED2B8%-(.#80/57RN4.-JC*HJN7U20B?A'VB
MT'5;C-+17UIGQ@&([0'M\P"=))\1*T>-Z#+<=VPEJ)7R+PIA.FA-H5IX_!4,
M)OI^ZQ_:.\P"3Z3N@BR7QL69);*\';UB0KNT*X[--N%"KO[]HU+E3(JWRU(V
MFUYE*W.8J)@KOGI-X!LOBB4YV]!6.>V^;6E1F* #S&/_4=&>SYNGC#$K$Z"-
MQ4S#*/IL*H;\K9.\U UAXM=B?OJ>-F< ZJPIQZEMB;;CR)28ZSCT8]B.[0WB
M"C[3Y,J@$2(W9MR6*TG465'WEI:XH .M4)>Y'=YEABTR6W0Y]78@-50FD\S(
M;Q6J(8<%6^D+GS+>$%ZY\+DV_A57JM36+_5O"^?"92P;7@5F1="Y()D\O30F
M9F% X&?B,S(;;'('8KU@B\L8X T8XBP62(_0$$F+'6RZ$ HBXB4IU<I&)D9U
MG<.>]*8 /WEU<GI^J._60"IL9VTE4MS=0]17GD=7)[+;K2ENFA9/LH'-(KE1
MD:!"#8-:WX3AF_ Q)VAC20/K@=,THH+=#H&O^WRL-;7#WL# \G)]\UDFQ0WQ
M47H2:8),-AKF\"G&H9AKT:$E@5)NRGEHE/(64PD)B\AAKPWM#%N8V^-#-2Y!
MT0,)3HMV53=2B2$,+-$=3O?Q D/W;D]]%6ZW)U_8[?9D[79[>&ZWU:3CD[OC
M6;JT%4UVS8FY-B?NERHGOCUGN;8>AT43:Y>01LOE(219F#5R)50+&K-Y86H?
M9'=#K1@E:D%1$*6L+ 6OV%EPB T3]W6A(H7X,-@6YV5;0:_W&ZLSP<-8/3(I
M2SB*PP[1.P,(<BI0A"82I5!G4LG7*^UIW!=@6?X^.V!&3DHW<'&9W778 =.M
M8W(%LN;5X'I0 =H^!BNP""EPA_B^5_K+*XDF?/A=F$,'2;'6\Q9(LF\I)9S5
M'N$)[-6?"Y/OXV^3MDWP[XC]#'% N9L9*RRC0FKT @<D"_CD')X+-;.;JOY
M0=EDFK?>"AMZ!,?-:SQYZ[4.K_5W[.?U21=PW3L,2Q>^@[U;6TDA'Z!-?\WI
MW!M>!Q9LZ+CD4D4*#2R@?.53<(X&YUWP\4A@ AMW@H>TDESRT8PI:4FBHB%Z
M#7L+Y%M=%0:YQUA$[)#-+:9BVH0,]6 #"=BOPP_6GN22VQ[P@3Y".D\:F; "
MCBLFL*B*IBL1-\(57FS1D"<+\JIQS-8+OA,*:VRZ<B+!^?2XL._A'-HG9.K(
M\C))ZQLXO['+G?72B,\2*<]NV%7!VJPGY#.W%3R,_XPKJL:668=2.I3G++;U
MRMD<12<./9,FD^0JH\^;UE368Y)SKZ(DO..767I%;I38UFB=)CD7;LU:&*M\
MR:2KKCT5RP.)6M5E-K<\+B-S$/AQEQ=SI1)!DK)'MT-S0X!^M(^$C0&K#3+,
M79AD&>BL&6#(ST1<FID4/E/*7 =%%"L(D59-JEJ7^0MQGP=Q2KEV_(7=4YA+
M/=A4L!J;0HW>!2'Y\=Q$-!$Y>WXIJLI%Y^:Q[X*<".PHKTUH"CT*&@PIG.PZ
M&-,!8^/QMT6E_#25T.+T 4%JIC^1@LIPSW'JD,P0:/]4+YZ\THD#6+LE#G5O
M$?A,+SKSJIIE=WGI"Q?/<TPW >Z*A;N80@PV>X=C6WHIN&W+4M$$&*BX,1PN
M$3D0XVG(@VI[*FS7"YNR)/OD4061"0(@E_A\FK&[.K/L:0(>&]7)+(TC,/(;
MS(>Y @G$I>?P[L1Z!Q/0;>7%E 14C$ \H-J]Z?N].W=MYXJ5+29W./+%81E5
M\=TZIVB/2"DVHM.=IY 8-<+22D=/KK*LVK@%O7R;V-OL"-O$U4N%/^J< YVS
MH!3+-\6X;>L9WSHP 5?D!:9/%!G(2)^)$>Q:'PW9JTOE?LN4^R81<&;W#<:V
MV#>IOQ$!1+A0(_*:&4P^]T-B=>K)*1)K39BEQS7%@FOIZ$F.Z "%C-U]UA]S
M!\M!8Q3:/8(B!A(#28%W=1O-LQO=E(G>'/5'33& @J"P(@"'>0UR P4#5M1E
MT6(+7L#F1_9TO%DV&72;-V"!\U:3@(D7K<"<SI:S"CJ?NZR8[L[@LJ4>-S7+
MT0:T(6B(Q*D.9#H^G:"T<%4J,=Y1YYISS9SI19(&#@$Z&HHYUVAI%(^HI1?1
MXD^ONONP&T8-*9QQ'X]3F2*](;HD$_^:%8932.(ZW$/+.:5"4O0%"H3MZ&2D
M[W++?SJ@HF.M)X&Z4^*#2$04LS24*P.W,;>SV%??\UQPXS;N-)FB0X8JV_4T
M&%G#?C6_3K%/"_%.FF8VX<_2;"1IMPR(HIL-.;*:K+"QUQN8MG'%, $K+.>4
M^CQM#?=%7]N9;T>'@0E;U"LV#BAJ:W./3$]$$FEU@G*?4:="QB\&\P0&Q >.
MKAZCP-K20$[?YY<XVMM6CB:G)"]03(('G,_QQD>&VO&0G("!EFP.O:$S9,^;
MQ]&Y:'TWYIN]F);4_F$\1:+O,O%EXNDB7Z1==PY-RCQ)WKU,OEUY.,S_NVFO
MG40=&"(TDLE6;ZNF>2DB71J)M6Q'MQO<[@0HP:[;+SB6I0$ 5%Y/@>UU!GWW
M^[ ^>UL<=Y#1D05I:FL.=D83W"QEA429&3O_:)N2]M?9JP'E2!*-4341GIC
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M\QWVN('X!YO$V? K5VKU+H"&VO$K"UE64(6)5$'INZ4Y8YFB^R>4[LE24L+
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MJ9K_I?$_4$L! A0#%     @ \(K55J?)ZL*H P  0 \  !$
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M4$L! A0#%     @ \(K55DQ=%O9%$P  U84  !,              ( !PQ4
M &)C9&$R,#(S,#8R,5\X:RYH=&U02P$"% ,4    " #PBM560WAR[3U=  !F
M' ( #0              @ $Y*0  97A?-3,V,C@Q+FAT;5!+ 0(4 Q0    (
M /"*U5;:+N<"( L  *PQ   -              "  :&&  !E>%\U,S8U-38N
9:'1M4$L%!@     '  < OP$  .R1      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
